Quick Answer
Cannabis Bioscience International Holdings, Inc. reported Operating Income Loss of -$421.4 thousand for the year ending 2025.
- Cannabis Bioscience International Holdings, Inc. showed an increase of +13.3% in Operating Income Loss from 2024 to 2025.
- This data is from Cannabis Bioscience International Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on September 22, 2025.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), Cannabis Bioscience International Holdings, Inc.'s Operating Income Loss has grown by 57.2%.
- Historical annual values: Fiscal year 2025: -$421.4 thousand | Fiscal year 2024: -$486.1 thousand | Fiscal year 2023: -$983.4 thousand.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: